Status:

UNKNOWN

COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy and With Primary Immune Deficiency

Lead Sponsor:

Tel-Aviv Sourasky Medical Center

Conditions:

Allogenic Hematopoietic Cell Transplant

CAR-T Therapy

Eligibility:

All Genders

18+ years

Brief Summary

The corona pandemic is a continuing global challenge due to Corona Virus 2019 (COVID-19). The purpose of the study is to confirm the accepted hypothesis from the recommendations of The European Socie...

Detailed Description

The study population will be allogeneic bone marrow transplant patients and those who have received CART therapy - immunocompromised patients who are vaccinated with COVID-19 in a commercial preparati...

Eligibility Criteria

Inclusion

  • Patients aged 18 and over
  • Patient sex - male and female
  • Bone marrow transplant from a donor (sibling or unrelated) or after cell therapy (CART) at least 3 months before vaccination.
  • Patients with primary immunodeficiency syndrome.
  • Patients who are able to sign an informed consent form

Exclusion

  • Patients under 18 years of age
  • Patients who are unable to give informed consent
  • Patients with acute GVHD who require steroid therapy above 0.5 mg / kg or who have been diagnosed in the last month.
  • Patients with chronic GVHD who require steroid therapy above 0.5 mg / kg
  • Patients treated with rituximab / immunoglobulins / mesenchymal cells during the last month.
  • Patients whose disease is not completely cured and receive dedicated treatment for the disease.
  • Patients receiving maintenance treatment for the underlying disease (excluding TKIs such as sorfenib, midostaurin, guiltritinib or cranolinib).
  • Patients who have previously had COVID19.
  • Patients with severe allergy to one of the vaccine components.

Key Trial Info

Start Date :

December 28 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 28 2021

Estimated Enrollment :

110 Patients enrolled

Trial Details

Trial ID

NCT04724642

Start Date

December 28 2020

End Date

December 28 2021

Last Update

January 28 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tel-Aviv Sourasky Medical Center

Tel Aviv, Israel, 6423906

COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy and With Primary Immune Deficiency | DecenTrialz